A sensitive, specific and accurate assay of analytes and biomarkers is critical for diagnosis and therapy. However, the complex nature of sample matrix challenges the measurement with a reliable result of low-yet-meaningful analytes. For instance, anaphylaxis is life threatening. Detection of preexisting allergen-specific IgE can identify vulnerable individuals. Our proprietary technology FocalTuning™ is uniquely designed to detect and quantify supper-low-level analytes such as polyethylene glycol (PEG) specific IgE. This platform also can be applied to early diagnosis of cancer and neural degenerative diseases.
The advantages of FocalTuning™ technology include, but are not limited to
- Minimum sample only (50µl or less)
- Unbeatable accuracy
- Super sensitive
- High specificity